🔗 Permalink

Inventor profile of:

Tsutomu Takeuchi

City:

Tokyo

Country:

Japan

Published Applications:

Last publication date:

2025-02-20

Top Assignees for applications by Tsutomu Takeuchi

The entities that hold a legal rights for patent applications filed by inventor Takeuchi Tsutomu:

KEIKO YOSHIMOTO 7 TOKYO, Japan
TSUTOMU TAKEUCHI 7 TOKYO, Japan
KOWA COMPANY, LTD. 6 Nagoya-shi, Japan
KEIO UNIVERSITY 4 Tokyo, Japan
KENSEI TSUZAKA 2 TOKYO, Japan
KOWA COMPANY, LTD. 1 Nagoya-shi, Aichi, Japan
JAPAN AS REPRESENTED BY DIRECTOR-GENERAL OF NATIONAL INSTITUTE OF INFECTIOUS DISEASES 1 Tokyo, Japan
DNA CHIP RESEARCH INC. 1 Kanagawa, Japan
Takeda Pharmaceutical Company Limited 1 Chuo-ku, Osaka-shi, Osaka, Japan
GLYCOBIOMARKER LEADING INNOVATION CO. LTD. 1 Tsukuba-shi, Ibaraki, Japan
SHIGA UNIVERSITY OF MEDICAL SCIENCE 1 Otsu-shi, Shiga, Japan
National Institute of Advanced Industrial Science and Technology 1 Tokyo, Japan
KOWA COMPANY, LTD. 1 Nogoya-shi, Aichi, Japan
The University of Tokyo 1 Tokyo, Japan
KEIO UNIVERSITY 1 Minato-ku, Tokyo, Japan
RIKEN 1 Wako-shi, Saitama, Japan
SAITAMA MEDICAL UNIVERSITY 1 Saitama, Japan

Recent patent applications by Takeuchi Tsutomu

Tsutomu Takeuchi from Tokyo, JP has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-02-20

US20250060370A1

Physics

METHOD OF TREATING AN AUTOIMMUNE DISEASE BY ADMINISTERING AN ANTI-HUMAN BAFF ANTIBODY

#2 | 2023-11-23

US20230374128A1

Chemistry; metallurgy

THERAPEUTIC AGENT FOR IMMUNE/INFLAMMATORY DISEASE

#3 | 2023-11-02

US20230348573A1

Chemistry; metallurgy

SARS-COV-2 NEUTRALIZING ANTIBODY OR FRAGMENT THEREOF

#4 | 2022-03-10

US20220073988A1

Chemistry; metallurgy

METHOD FOR PREDICTING EFFICACY OF RHEUMATOID ARTHRITIS THERAPEUTIC AGENT AND BIOMARKER USED THEREIN

#5 | 2021-12-23

US20210393634A1

Human necessities

Prophylactic and/or therapeutic agent for inflammatory diseases which contains pyrrolopyrimidine compound as active ingredient

#6 | 2021-07-15

US20210215705A1

Physics

ANTIHUMAN BAFF ANTIBODY

#7 | 2017-11-23

US20170336413A1

Physics

RHEUMATOID ARTHRITIS MARKER

#8 | 2015-02-12

US20150045244A1

Chemistry; metallurgy

METHOD FOR DETERMINING RHEUMATOID ARTHRITIS ACTIVITY INDICATOR, AND BIOMARKER USED THEREIN

#9 | 2014-01-23

US20140024055A1

Physics

ANTIHUMAN BAFF ANTIBODY

#10 | 2011-09-29

US20110236899A1

Chemistry; metallurgy

Method and Apparatus for Predicting Pharmaceutical Efficacy of Anti-TNFa Antibody Drug Against Rheumatoid Arthritis

#11 | 2011-04-07

US20110081351A1

Physics

ANTIHUMAN BAFF ANTIBODY

#12 | 2010-08-05

US20100196948A1

Chemistry; metallurgy

Method of screening baff suppressor or inhibitor

#13 | 2008-12-11

US20080305502A1

Chemistry; metallurgy

Method of screening Baff suppressor or inhibitor

#14 | 2008-02-28

US20080050381A1

Physics

Antihuman Baff Antibody

InventorID:

622790 ⎘